S&P 500   2,994.30 (+0.15%)
DOW   26,989.06 (-0.05%)
QQQ   193.09 (+0.03%)
AAPL   233.95 (-0.18%)
FB   189.55 (+0.00%)
MSFT   139.23 (-0.84%)
GOOGL   1,251.95 (+0.72%)
AMZN   1,788.00 (+0.59%)
CGC   20.21 (+2.43%)
NVDA   192.86 (-0.70%)
MU   45.42 (+0.58%)
BABA   176.38 (-0.42%)
GE   9.08 (+1.91%)
TSLA   260.99 (+0.48%)
AMD   30.97 (+0.52%)
F   9.11 (+0.44%)
ACB   3.79 (+4.99%)
NFLX   297.91 (+4.06%)
GILD   65.06 (-0.44%)
DIS   132.72 (+1.42%)
S&P 500   2,994.30 (+0.15%)
DOW   26,989.06 (-0.05%)
QQQ   193.09 (+0.03%)
AAPL   233.95 (-0.18%)
FB   189.55 (+0.00%)
MSFT   139.23 (-0.84%)
GOOGL   1,251.95 (+0.72%)
AMZN   1,788.00 (+0.59%)
CGC   20.21 (+2.43%)
NVDA   192.86 (-0.70%)
MU   45.42 (+0.58%)
BABA   176.38 (-0.42%)
GE   9.08 (+1.91%)
TSLA   260.99 (+0.48%)
AMD   30.97 (+0.52%)
F   9.11 (+0.44%)
ACB   3.79 (+4.99%)
NFLX   297.91 (+4.06%)
GILD   65.06 (-0.44%)
DIS   132.72 (+1.42%)
Log in

LifeVantage Stock Price, News & Analysis (NASDAQ:LFVN)

$14.40
+0.01 (+0.07 %)
(As of 10/17/2019 12:08 PM ET)
Today's Range
$14.28
Now: $14.40
$14.78
50-Day Range
$11.81
MA: $13.37
$14.57
52-Week Range
$10.16
Now: $14.40
$17.08
Volume1,716 shs
Average Volume115,115 shs
Market Capitalization$203.33 million
P/E Ratio24.49
Dividend YieldN/A
Beta0.65
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs. It also provides skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, and micro-lift serums; and Hair Care System under the TrueScience brand name. The company sells its products through a direct sales model, as well as a network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands, Germany, Spain, and Taiwan. LifeVantage Corporation is headquartered in Sandy, Utah.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LFVN
CUSIPN/A
Phone801-432-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$225.96 million
Cash Flow$0.77 per share
Book Value$1.90 per share

Profitability

Net Income$7.43 million

Miscellaneous

Employees220
Market Cap$203.33 million
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable

Receive LFVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LFVN and its competitors with MarketBeat's FREE daily newsletter.


LifeVantage (NASDAQ:LFVN) Frequently Asked Questions

What is LifeVantage's stock symbol?

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

How will LifeVantage's stock buyback program work?

LifeVantage announced that its Board of Directors has authorized a stock buyback plan on Tuesday, November 28th 2017, which permits the company to repurchase $5,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its stock is undervalued.

How were LifeVantage's earnings last quarter?

LifeVantage Corp (NASDAQ:LFVN) released its earnings results on Wednesday, August, 14th. The company reported $0.26 EPS for the quarter. The business had revenue of $56.17 million for the quarter. LifeVantage had a return on equity of 36.85% and a net margin of 3.29%. View LifeVantage's Earnings History.

When is LifeVantage's next earnings date?

LifeVantage is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for LifeVantage.

What guidance has LifeVantage issued on next quarter's earnings?

LifeVantage issued an update on its FY 2020 earnings guidance on Wednesday, August, 14th. The company provided EPS guidance of $0.62-0.71 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.50. The company issued revenue guidance of $235-245 million, compared to the consensus revenue estimate of $226.94 million.

Has LifeVantage been receiving favorable news coverage?

News stories about LFVN stock have been trending very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. LifeVantage earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for LifeVantage.

Who are some of LifeVantage's key competitors?

What other stocks do shareholders of LifeVantage own?

Who are LifeVantage's key executives?

LifeVantage's management team includes the folowing people:
  • Mr. Darren Jay Jensen, Pres, CEO & Director (Age 50)
  • Mr. Steven R. Fife, Chief Financial Officer (Age 58)
  • Mr. Charles J. Wach, Chief Operating Officer (Age 57)
  • Mr. Kevin McMurray, Gen. Counsel
  • Mr. Ryan Goodwin, Chief Marketing Officer (Age 42)

Who are LifeVantage's major shareholders?

LifeVantage's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Bowling Portfolio Management LLC (0.26%). Company insiders that own LifeVantage stock include Darren Jay Jensen, Garry Paul Mauro and Raymond B Greer. View Institutional Ownership Trends for LifeVantage.

Which institutional investors are buying LifeVantage stock?

LFVN stock was acquired by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC. Company insiders that have bought LifeVantage stock in the last two years include Darren Jay Jensen, Garry Paul Mauro and Raymond B Greer. View Insider Buying and Selling for LifeVantage.

How do I buy shares of LifeVantage?

Shares of LFVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is LifeVantage's stock price today?

One share of LFVN stock can currently be purchased for approximately $14.40.

How big of a company is LifeVantage?

LifeVantage has a market capitalization of $203.33 million and generates $225.96 million in revenue each year. The company earns $7.43 million in net income (profit) each year or $0.59 on an earnings per share basis. LifeVantage employs 220 workers across the globe.View Additional Information About LifeVantage.

What is LifeVantage's official website?

The official website for LifeVantage is http://www.lifevantage.com/.

How can I contact LifeVantage?

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The company can be reached via phone at 801-432-9000 or via email at [email protected]


MarketBeat Community Rating for LifeVantage (NASDAQ LFVN)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  113 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about LifeVantage and other stocks. Vote "Outperform" if you believe LFVN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LFVN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel